Edwards Lifesciences (NYSE: EW) — Company Overview, News & Financial Data
Edwards Lifesciences develops heart valve and monitoring technologies aimed at improving outcomes in cardiovascular care.
Edwards Lifesciences
Edwards Lifesciences is a medical technology company specializing in structural heart disease innovations and cardiac monitoring solutions. Headquartered in Irvine, California, the organization designs, manufactures, and markets medical devices for cardiovascular therapies worldwide. Its product portfolio includes transcatheter aortic valve replacement systems, transcatheter mitral and tricuspid valve repair and replacement technologies, surgical heart valves, and implantable heart failure monitoring systems. The company serves hospitals, cardiac care centers, and healthcare professionals, maintaining manufacturing, research, and distribution infrastructure across North America, Europe, and Asia to deliver therapeutic options for severe heart conditions.
Snapshot
Operations
Products and/or services of Edwards Lifesciences
- Transcatheter Heart Valve Technologies: Minimally invasive replacement heart valves and catheter delivery systems, including the SAPIEN valve family, designed to treat severe aortic valve stenosis across major global healthcare markets without requiring open-heart surgery.
- Transcatheter Mitral and Tricuspid Technologies: Specialized catheter-based repair and replacement systems, including the PASCAL repair device and EVOQUE tricuspid replacement system, developed to treat complex mitral and tricuspid structural valve regurgitation in adult patient populations.
- Surgical Heart Valve Therapies: Fabricated tissue heart valves, annuloplasty repair rings, and surgical accessories, incorporating advanced tissue technologies like RESILIA, used by cardiac surgeons during traditional open-heart surgical procedures to restore cardiovascular function.
- Implantable Heart Failure Management: Sensor-based implantable cardiovascular monitoring solutions and pulmonary artery pressure management devices, engineered to deliver continuous clinical data for managing patients suffering from advanced structural heart failure and related conditions.
- Pediatric Surgical Valve Support: Specialized cardiac surgical products, custom valve conduits, and tailored structural devices specifically engineered for pediatric patients and congenital heart defect repair procedures performed in specialized surgical centers.
- Clinical Research and Medical Education: Professional support services including multi-center clinical trials, procedural training programs, reimbursement assistance, and technical consultation delivered to hospital cardiac care teams, interventional cardiologists, and cardiothoracic surgical specialists.
Edwards Lifesciences executive team
- Mr. Bernard J. ZovighianCEO & Director
- Mr. Scott B. UllemCorporate VP & CFO
- Mr. Donald E. Bobo Jr.Corporate Vice President of Strategy & Corporate Development
- Mr. Jean-Luc LemercierCorporate Vice President of Japan, Asia Pacific & Greater China
- Mr. Daveen ChopraCorporate Vice President of Transcatheter Mitral & Tricuspid Therapies
- Mr. Andrew M. DahlPrincipal Accounting Officer, Senior VP & Corporate Controller
- Dr. Todd J. Brinton FACC, M.D.Corporate VP of Advanced Innovation & Technology and Chief Scientific Officer
- Mr. Snehashish SarkarSenior VP, Chief Information & Digital Officer
- Mr. Mark D. PetersonCorporate VP & General Counsel
- Mr. Dirksen J. LehmanCorporate Vice President of Public Affairs